Lichen sclerosus et atrophicus

DOI: https://doi.org/10.29296/25877305-2018-08-07
Download full text PDF
Issue: 
8
Year: 
2018

Yu. Semenchak; Professor E. Snarskaya, MD I.M. Sechenov First Moscow State Medical University (Sechenov University)

The paper presents an update on lichen sclerosus et atrophicus (its etiology and pathogenesis, clinical presentations, classification, differential diagnosis, and treatment), a chronic autoimmune dermatosis, one of the clinical variants of circumscribed scleroderma.
Keywords: 
dermatology
circumscribed scleroderma
lichen sclerosus et atrophicus
anogenital localization
vulvar lichen
penile lichen
sexually transmitted infections
treatment

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Guseva N.G. Sistemnaja sklerodermija – mul'tidistsiplinarnaja problema // Nauchno-prakt. revmatol. – 2011; 2: 10–4.
  2. Higgins C., Cruickshank M. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus // J. Obstet. Gynaecol. – 2012; 32: 271–5.
  3. McPherson T., Cooper S. Vulval lichen sclerosus and lichen planus // Dermatol. Ther. – 2010; 23: 523–32.
  4. Edmonds E., Hunt S., Hawkins D. et al. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients // J. Eur. Acad. Dermatol. Venereol. – 2012; 26: 730–7.
  5. Molochkov V.A., Snarskaja E.S., Romashkina A.S. Ochagovaja sklerodermija, assotsiirovannaja s drugimi autotimmunnymi zabolevanijami i spektrom razlichnyh autoantitel // Ros. zhurn. kozhnyh i venericheskih boleznej. – 2011; 4: 33–6.
  6. Goldstein A., Marinoff S., Christopher K. et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice // J. Reprod. Med. – 2005; 50: 477–80.
  7. Kreuter A., Kryvosheyeva Y., Terras S. et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients // Acta Derm. Venereol. – 2013; 93: 238–41.
  8. Powell J., Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem // J. Am. Acad. Dermatol. – 2001; 44: 803–6.
  9. Kizer W., Prarie T., Morey A. Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system // South Med. J. – 2003; 96: 9–11.
  10. Nelson D., Peterson A. Lichen sclerosus: epidemiological distribution in an equal access health care system // J. Urol. – 2011; 185: 522–5.
  11. Bleeker M., Visser P., Overbeek L. et al. Lichen sclerosus: Incidence and risk of vulvar squamous cell carcinoma // Cancer Epidemiol. Biomark. Prev. – 2016; 25: 1224–30.
  12. Kirtschig G., Kuik D. A Dutch cohort study confirms familial occurrence of anogenital lichen sclerosus // J. Women’s Health Care. – 2014; 3: 209–11.
  13. Sokolova A.A, Grebenjuk V.N., Dolja O.V. Klinicheskie osobennosti genital'nogo skleroatroficheskogo lihena u muzhchin i zhenschin // Klin. dermatol. i venerol. – 2016; 1: 54–9.
  14. Smith S., Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: A prospective case series // Pediatr. Dermatol. – 2009; 26: 725–9.
  15. Sokolova A.A., Grebenjuk V.N., Dolja O.V. Klinicheskaja harakteristika skleroatroficheskogo lihena u detej // Klin. dermatol. i venerol. – 2015; 1: 75–8.
  16. Padmavathy L., Lakshmana Rao, Dana Laksnmi et al. Lichen sclerosus et atrophicus in the Areolae: A case report // Case Rep. Dermatol. Med. – 2012; 3: 1–3.
  17. Sherman V., McPherson T., Baldo M. et al. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study // J. Eur. Acad. Dermatol. Venereol. – 2010; 24: 1031–4.
  18. Birenbaum D., Young R. High prevalence of thyroid disease in patients with lichen sclerosus // J. Reprod. Med. – 2007; 52: 28–30.
  19. Murphy R. Lichen sclerosus // Dermatol. Clin. – 2010; 28: 707–15.
  20. Leese G., Flynn R., Jung R. et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS) // Clin. Endocrinol. (Oxf). – 2008; 68: 311–6.
  21. Hofer M., Meeks J., Mehdiratta N. et al. Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking // World J. Urol. – 2014; 32: 105–8.
  22. Gao X., Barnardo M., Winsey S. et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus // J. Invest. Dermatol. – 2005; 125: 895–9.
  23. Howard A., Dean D., Cooper S. et al. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva // Aust. J. Dermatol. – 2004; 45: 12–5.
  24. Baldo M., Bailey A., Bhogal B. et al. T-cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus // J. Eur. Acad. Dermatol. Venereol. – 2010; 24: 186–90.
  25. Gambichler T., Hoxtermann S., Skrygan M. et al. Occurrence of circulating anti-bullous pemphigoid antibodies in patients with lichen sclerosus // J. Eur. Acad. Dermatol. Venereol. – 2011; 25: 369–70.
  26. Gambichler T., Terras S., Kreuter A. et al. Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus – further support for epigenetic mechanisms // Br. J. Dermatol. – 2014; 170: 687–93.
  27. Patsatsi A., Kyriakou A., Mantas A. et al. Circulating anti-BP180 NC16a and anti-BP230 autoantibodies in patients with genital lichen sclerosus do not correlate with the disease activity and pruritus // Acta Dermatol. Venereol. – 2014; 94: 711–2.
  28. Abdelbaky A., Aluru P., Keegan P. et al. Development of male genital lichen sclerosus in penile reconstruction skin grafts after cancer surgery: an unreported complication // BJU Int. – 2012; 109: 776–9.
  29. Neill S., Lewis F., Tatnall F. et al. British Association of Dermatologists guidelines for the management of lichen sclerosus 2010 // Br. J. Dermatol. – 2010; 163: 672–82.
  30. Rimoin L., Kwatra S., Yosipovitch G. Female-specific pruritus from childhood to post- menopause: clinical features, hormonal factors, and treatment considerations // Dermatol. Ther. – 2013; 26 (2): 157–67.
  31. Taylor A., Guzail M., Al-Azzawi F. Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis // Br. J. Dermatol. – 2008; 158 (2): 319–28.
  32. Burova E.A. Skleroatroficheskij lihen vul'vy u detej. Osobennosti kliniki, patogeneza, lechenija. Avtoref. dis. ... kand. med. nauk. M., 1989.
  33. Aidé S., Lattario F., Almeida G. et al. Epstein-Barr virus and human papillomavirus infection in vulvar lichen sclerosus // J. Low Genit. Tract. Dis. – 2010; 14 (4): 319–22.
  34. Stepanova E.V. Papillomovirusnaja infektsija pri skleroticheskom lishae i rake vul'vy. Avtoref. dis. ... kand. med. nauk. M., 2004.
  35. Reutskaja M.A., Kulinich S.I. Rol' infektsij v geneze zabolevanij vul'vy // Sib. med. zhurn. – 2010; 6: 239–42.
  36. Sharapova L.E. K voprosu ob etiologii i patogeneze hronicheskih distroficheskih zabolevanij vul'vy // Ros. vestn. akush. i ginekol. – 2010; 1: 29–34.
  37. Bono W., Dupin N. Localized scleroderma (morphea) // Presse Med. – 2007; 19 (Suppl. 2): 32–7.
  38. Dvornikov A.S. Terapija bol'nyh lokalizovannoj sklerodermiej preparatom gialuronidazy // Vestn. dermatol. i venerol. – 2013; 3: 96–100.
  39. Wallace H. Lichen sclerosus et atrophicus. Transactions’s of the St. John’s Hospital // Dermatol. Soc. – 1971; 57: 9–30.
  40. Cooper S., Gao X., Powell J. et al. Does treatment of vulvar lichen sclerosus influence its prognosis? // Arch. Dermatol. – 2004; 140: 702–6.
  41. Simpkin S., Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: a possible association with psoriasis // Australas J. Dermatol. – 2007; 48: 28–31.
  42. Bunker C. Zabolevanija polovyh organov u muzhchin. V kn.: Dermatologija Fitspatrika v klinicheskoj praktike. V 3 t. K. Vol'f, L.A. Gol'dmit, S.I. Kats i dr. Per. s angl. Pod obsch. red. akad. A.A. Kubanovoj / M.: Izdatel'stvo Panfilova: BINOM. Laboratorija znanij, 2012; 1202: 731–2.
  43. Krjazheva S.S., Romashkina A.S. Porazhenie naruzhnyh polovyh organov pri razlichnyh formah ogranichennoj sklerodermii // Aktual'nye voprosy dermatovenerologii i dermatoonkologii. – 2009; 6: 49–50.
  44. Schlosser B., Mirowski G. Lichen sclerosus and lichen planus in women and girls // Clin. Obstet. Gynecol. – 2015; 58: 125–42.
  45. Chiang K., Chang K., Wong T. et al. Linear scleroderma «en coup de sabre»: initial presentation as intractable partial seizures in a child // Pediatr. Neonatol. – 2009; 50: 294–8.
  46. Torgerson R. Zabolevanija polovyh organov u zhenschin. V kn.: Dermatologija Fitspatrika v klinicheskoj praktike. V 3 t. K. Vol'f, L.A. Gol'dmit, S.I. Kats i dr. Per. s angl. Pod obsch. red. akad. A.A. Kubanovoj / M.: Izdatel'stvo Panfilova: BINOM. Laboratorija znanij, 2012; T. 1: 42–3.
  47. Pugliese J., Morey A., Peterson A. Lichen sclerosus: review of literature and current recommendations for management // J. Urol. – 2007; 178: 2268–76.
  48. Wang S., Chi C., Wong Y. et al. Genital verrucous carcinoma is associated with lichen sclerosus: a retrospective study and review of the literature // J. Eur. Acad. Dermatol. Venereol. – 2010; 24: 815–9.
  49. Mannweiler S., Sygulla S., Winter E. et al. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression // J. Am. Acad. Dermatol. – 2013; 69: 73–81.
  50. Fitspatrik T., Dzhonson R., Vul'f K. i dr. Dermatologija. Atlas-spravochnik. Per. s angl. Mak-Grou-Hill / M.: Praktika, 2015; s. 286–9.
  51. Jusupova L.A., Filatova M.A. Lokalizovannaja sklerodermija: diagnostika, klinika, lechenie // Lechaschij vrach. – 2014; 5: 51–5.
  52. Vilela F., Carneiro S., Ramos-e-Silva M. Treatment of morphea or localized scleroderma: review of the literature // J. Drugs Dermatol. – 2010; 9: 1213–9.
  53. Zwischenberger B., Jacobe H. A systematic review of morphea treatments and therapeutic algorithin // J. Am. Acad. Dermatol. – 2011; 65: 925–41.
  54. Funaro D., Lovett A., Leroux N. et al. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% vs. topical tacrolimus 0.1% in patients with vulvar lichen sclerosus // J. Am. Acad. Dermatol. – 2014; 71: 84–91.
  55. Valdivielso-Ramos M., Bueno C., Hernanz J. Significant improvement in extensive lichen sclerosus with tacrolimus oint- ment and PUVA // Am. J. Clin. Dermatol. – 2008; 9: 175–9.
  56. Virgili A., Lauriola M., Mantovani L. et al. Vulvar lichen sclerosus: 11 Women treated with tacrolimus 0.1% ointment // Acta Dermatol. Venerol. – 2007; 87: 69–72.
  57. Burrows L., Creasey A., Goldstein A. The treatment of vulvar lichen sclerosus and female sexual dysfunction // J. Sex Med. – 2011; 8: 219–22.
  58. Chi C., Kirtschig G., Baldo M. et al. Topical interventions for genital lichen sclerosus // Cochrane Database Syst. Rev. – 2011; 12: 40–58.
  59. Gunthert A., Faber M., Knappe G. et al. Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives // Eur. J. Obstet., Gynecol., Reprod. Biol. – 2008; 137: 56–60.
  60. Buense R., Duarte I., Bouer M. Localized scleroderma: assessment of the therapeutic response to phototherapy // An. Bras. Dermatol. – 2012; 87: 63–9.